ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
AzurRx BioPharma Inc

AzurRx BioPharma Inc (AZRX)

3.45
0.00
(0.00%)
Closed January 04 4:00PM
0.00
0.00
(0.00%)

Professional-Grade Tools, for Individual Investors.

Key stats and details

Current Price
3.45
Bid
3.41
Ask
3.51
Volume
-
0.00 Day's Range 0.00
0.00 52 Week Range 0.00
Market Cap
Previous Close
3.45
Open
-
Last Trade
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
-
Shares Outstanding
13,500,000
Dividend Yield
-
PE Ratio
-2.48
Earnings Per Share (EPS)
-1.19
Revenue
-
Net Profit
-16.1M

About AzurRx BioPharma Inc

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Headquarters
Dover, Delaware, USA
Founded
-

AZRX Latest News

AzurRx BioPharma to Change Corporate Name to First Wave BioPharma Today

BOCA RATON, Fla., Sept. 21, 2021 (GLOBE NEWSWIRE) -- AzurRx BioPharma, Inc. (NASDAQ: AZRX) (“First Wave” or the “Company”), a clinical-stage biopharmaceutical company specializing in the...

AzurRx BioPharma CEO Issues Letter to Shareholders Regarding Recent Acquisition of First Wave Bio and Creation of First Wave BioPharma

BOCA RATON, Fla., Sept. 14, 2021 (GLOBE NEWSWIRE) -- AzurRx BioPharma, Inc. (NASDAQ:AZRX), (“First Wave BioPharma” or the “Company”), a clinical-stage biopharmaceutical company specializing in...

AzurRx BioPharma Announces Acquisition of First Wave Bio and its Proprietary Niclosamide Formulations Targeting Multi-Billion Dollar Inflammatory Bowel Disease Indications

AzurRx BioPharma to be renamed “First Wave BioPharma” and trade under new NASDAQ ticker symbol, “FWBI” Three IBD clinical indications, including ulcerative colitis and Crohn’s disease, added to...

AzurRx BioPharma Announces Reverse Stock Split

BOCA RATON, Fla., Sept. 10, 2021 (GLOBE NEWSWIRE) -- AzurRx BioPharma, Inc. (NASDAQ: AZRX), (“AzurRx” or the “Company”), a clinical stage biopharmaceutical company specializing in the...

AzurRx BioPharma Activates New Clinical Trial Sites in India for Phase 2 RESERVOIR Trial Evaluating Niclosamide for the Treatment of COVID-19 Gastrointestinal Infections

BOCA RATON, Fla., Sept. 10, 2021 (GLOBE NEWSWIRE) -- AzurRx BioPharma, Inc. (“AzurRx” or the “Company”) (NASDAQ: AZRX), a company specializing in the development of targeted non-systemic...

AzurRx BioPharma Announces Positive Results from Independent Data Monitoring Committee Review of Safety Data from Part 1 of RESERVOIR Phase 2 Clinical Trial of Niclosamide for the Treatment of COVID-19 Gastrointestinal Infections

Review of Interim Safety Data Concluded with Favorable Recommendation to Continue RESERVOIR Trial as Planned Part 2 of RESERVOIR Trial to Enroll Up to 150 Patients to Evaluate Efficacy of FW-1022...

AzurRx BioPharma to Present at the Virtual H.C. Wainwright 23rd Annual Global Investment Conference

BOCA RATON, Fla., Sept. 07, 2021 (GLOBE NEWSWIRE) -- AzurRx BioPharma, Inc. (“AzurRx” or the “Company”) (NASDAQ: AZRX), a company specializing in the development of targeted...

AzurRx BioPharma Announces Positive Topline Data For Phase 2 MS1819 Combination Therapy Trial in Cystic Fibrosis Patients with Severe Exocrine Pancreatic Insufficiency (EPI)

MS1819 and PERT combination therapy achieves primary and secondary outcome measure endpointsStudy data indicates clinically meaningful improvement in coefficient of fat absorption (CFA) primary...

AzurRx BioPharma Announces WHO Publication of “Adrulipase Alfa” as International Nonproprietary Name for MS1819

BOCA RATON, Fla., Aug. 17, 2021 (GLOBE NEWSWIRE) -- AzurRx BioPharma, Inc. (“AzurRx” or the “Company”) (NASDAQ: AZRX), a company specializing in the development of targeted...

AzurRx BioPharma Announces Appointment of Terry Coelho to its Board of Directors

BOCA RATON, Fla., Aug. 16, 2021 (GLOBE NEWSWIRE) -- AzurRx BioPharma, Inc. (“AzurRx” or the “Company”) (NASDAQ: AZRX), a company specializing in the development of targeted non-systemic...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000CS
40000000CS
120000000CS
260000000CS
520000000CS
1560000000CS
2600000000CS

AZRX - Frequently Asked Questions (FAQ)

What is the current AzurRx BioPharma share price?
The current share price of AzurRx BioPharma is $ 3.45
How many AzurRx BioPharma shares are in issue?
AzurRx BioPharma has 13,500,000 shares in issue
What is the market cap of AzurRx BioPharma?
The market capitalisation of AzurRx BioPharma is USD 46.58M
What is the 1 year trading range for AzurRx BioPharma share price?
AzurRx BioPharma has traded in the range of $ 0.00 to $ 0.00 during the past year
What is the PE ratio of AzurRx BioPharma?
The price to earnings ratio of AzurRx BioPharma is -2.48
What is the reporting currency for AzurRx BioPharma?
AzurRx BioPharma reports financial results in USD
What is the latest annual profit for AzurRx BioPharma?
The latest annual profit of AzurRx BioPharma is USD -16.1M
What is the registered address of AzurRx BioPharma?
The registered address for AzurRx BioPharma is 850 NEW BURTON ROAD, SUITE 201, KENT, DOVER, DELAWARE, 19904
What is the AzurRx BioPharma website address?
The website address for AzurRx BioPharma is www.enterothera.com
Which industry sector does AzurRx BioPharma operate in?
AzurRx BioPharma operates in the PHARMACEUTICAL PREPARATIONS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
FCUVFocus Universal Inc
$ 0.9499
(174.93%)
260.93M
NITON2OFF Inc
$ 2.6306
(145.85%)
358.28M
CRNCCerence Inc
$ 19.33
(143.76%)
161.8M
KITTNauticus Robotics Inc
$ 3.8249
(140.56%)
104.8M
ACONAclarion Inc
$ 0.2984
(110.14%)
305.64M
HWHHWH International Inc
$ 0.4621
(-28.80%)
7.43M
SMSTDefiance Daily Target 2x Short MSTR ETF
$ 5.69
(-26.30%)
24.77M
RAINRain Enhancement Technologies Holdco Inc
$ 5.59
(-23.42%)
161.15k
PTLEPTL Ltd
$ 9.35
(-23.30%)
1.04M
NXUNXU Inc
$ 0.725868
(-22.78%)
7.59M
NITON2OFF Inc
$ 2.6306
(145.85%)
358.28M
TGLTreasure Global Inc
$ 0.382
(101.58%)
337.5M
ACONAclarion Inc
$ 0.2984
(110.14%)
305.64M
FCUVFocus Universal Inc
$ 0.9499
(174.93%)
260.93M
NVDANVIDIA Corporation
$ 144.47
(4.45%)
230.01M

Discussion

View Full Feed
PennyStockTrader2 PennyStockTrader2 3 minutes ago
yeah I believe Ward walked out of a meeting with this guy trying to bribe Mirage which will never happen. We either get a deal free and clear of corruption or no deal at all. Hopefully this new administration will see that through and do the right thing. Evidently the people Ward is working with in
MRGE
ducci1 ducci1 4 minutes ago
Charts: ES-- Very Nice 2 Day Rising Wedge ES 5 min ---Should Play Out Monday ! Looks like Previous Posted Head & Shoulders Pattern ( Double Bottom) may have been marked reversal ??
SPY
Huggy Bear Huggy Bear 5 minutes ago
Are public message boards expected to be boiler rooms as depicted in The Wolf of Wall St?
HMBL
sam1933 sam1933 5 minutes ago
Analysts Forecast $10 HBAR by 2025 Amid Positive HBAR News and Hedera Hashgraph ETF Rumors
January 4th, 2025 at 7:11 pm UTC · 5 mins read

https://www.coinspeaker.com/analysts-forecast-10-hbar-by-2025/
HBARUSD
Jack Torrance Jack Torrance 6 minutes ago
Correct. If people think that patients are going to walk into a doctor's office and get a tab of street-grade LSD for their condition, they are beyond wrong. Like you said, MM120 is an LSD derivative. And if approved, ONLY MM120 will be allowed to be prescribed and taken by patients. Besides being a
MNMD
Sideem Sideem 6 minutes ago
You got the n & x flipped. Loving the website. Good find.

https://blackberry.qnx.com/en
BB
TenKay TenKay 7 minutes ago
That’s the “go to” when things aren’t going as expected.
HMBL
StockItOut StockItOut 8 minutes ago
And yet I proved you lie and fabricate!

Fact!
XERI
TenKay TenKay 8 minutes ago
LOL…you literally just need to glance down on any of my posts to answer your question! LMAO.
2) Why am I here?
Answer: I like debating things that I have a 95% chance of being right about.
Some of you guys just crack me up…
HMBL
ignatiusrielly35 ignatiusrielly35 8 minutes ago
Maybe you should ask the numerous medical experts who signed off on the peer review paper why they apparently don't care about the issue you raise. How likely do you think it is that you've identified a flaw that somehow these people failed to consider? Assign a percentage, you vs. them.
AVXL
skitahoe skitahoe 10 minutes ago
Under compassionate use in the UK they've allowed patients with all sorts of solid cancers to purchase DCVax-L. They don't have to pay for DCVax-L through their medical system for other than what they approved it for, but I believe they'll allow it to be purchased for other uses, just as they did w
NWBO
gemstar66 gemstar66 10 minutes ago
Chance, from that photo, they are ready to start mining ASAP! Money will start flooding in soon. Love it.
AABB
nranger nranger 11 minutes ago
Thank you for your posts. I don't understand the negatvity about escrows. They can't be traded. It's like some psoters are intent on you selling them. But COOP has been very good to us. Why not some posts about why COOP is trading 44% below fair value. See simplywallstreet.com.
COOP
PennyStockTrader2 PennyStockTrader2 11 minutes ago
yea that was a great find ...

it also mentions "announcement of pipelines to new states" which matches up nicely to one of Mirage project announcements my goodness almost 5 years ago and till in our intro page: "Announces it has signed an agreement with ENERGY AGENCY OF THE STATE OF
MRGE
Homebrew Homebrew 12 minutes ago
Good luck using logic. Everything is just "shorts" and "bashers" to them.
HMBL
ducci1 ducci1 13 minutes ago
Charts: SPX-- Mkt Up Friday on SPX 30 min R3 on Macd ! ( Mon--Thurs 3 lower lows---Macd 3 Higher Hi's )--Bang Away She Went !!
SPY
PennyStockTrader2 PennyStockTrader2 16 minutes ago
yeah thats taken at the port of Coatzacoalcos as part of working on the isthmus project to transport oil across the isthmus which is great project especially with all the issues of the Panama Canal. Granted thats not natural gas but it all could be related we dont really know. But he clearly has re
MRGE
Au$tin Au$tin 16 minutes ago
Literally not going to...if you don't like the stock get off the board... your not convincing anyone to sell...
HMBL
beartrap12 beartrap12 16 minutes ago
Corner is pioneering a new class of multi-purpose immunotherapies that protect the young and old. Our versatile dendritic cell hyperactivation (hDC) platform induces exceptional memory T cell responses that provide robust and durable immunity against a virtually unbounded range of cancers and infect
NWBO
TenKay TenKay 17 minutes ago
“Why are you here?“



read my sig. it literally answers that’s exact question.
HMBL
getmoreshares getmoreshares 20 minutes ago
thanks
ZHUD
ducci1 ducci1 20 minutes ago
Pivot Calcs: SPX Pivot--5926----R1--5965----R2--5988----S1--5903----S2--5864-----SPY Pivot--589----R1--593----S1--587-----VIX Pivot--16.72--(Lower Pivot!) !!LOL!!
SPY
Au$tin Au$tin 21 minutes ago
Why are you here?
HMBL
mentholman mentholman 21 minutes ago
Order filled @2.384
XRPUSD
StonkMaster StonkMaster 21 minutes ago
Sorry? Do Explain.
NWBO